Cullinan Therapeutics, Inc. Common Stock (CGEM) News
Latest headlines that mention CGEM, newest first · each headline opens the original publisher
- Last price
- $14.54
- Day change
- +1.18%
- Next earnings
- 2026-11-05
CGEM headlines
latest coverageBiotech stocks widely slumped Wednesday, with Rapport Therapeutics, Climb Bio and Cullinan Therapeutics among some of the hardest-hit names. The post The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data appeared first on Investor's…
CGEM news alerts
Get an alert by email or push when a new headline mentions CGEM.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.